TheraRadar

AbbVie

183 active trials across 18 therapeutic areas

183
Active Trials
62
Phase 1
59
Phase 2
74
Phase 3
18
Therapeutic Areas
Portfolio Concentration: 62% of active trials in Oncology

Oncology

113 active / 235 total

Hepatology

0 active / 3 total

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)